Literature DB >> 28559933

Nuclear Medicine in the Era of Precision Medicine.

Byeong-Cheol Ahn1.   

Abstract

Year:  2017        PMID： 28559933      PMCID： PMC5429305          DOI： 10.1007/s13139-017-0478-5

Source DB:  PubMed          Journal:  Nucl Med Mol Imaging        ISSN： 1869-3474


× No keyword cloud information.
  9 in total

1.  Precision medicine.

Authors:  Orli Bahcall
Journal:  Nature       Date:  2015-10-15       Impact factor: 49.962

2.  Radioiodine Scan Index: A Simplified, Quantitative Treatment Response Parameter for Metastatic Thyroid Carcinoma.

Authors:  Jong-Ryool Oh; Byeong-Cheol Ahn; Shin Young Jeong; Sang-Woo Lee; Jaetae Lee
Journal:  Nucl Med Mol Imaging       Date:  2015-04-28

3.  Applications of molecular imaging in drug discovery and development process.

Authors:  Byeong-Cheol Ahn
Journal:  Curr Pharm Biotechnol       Date:  2011-04       Impact factor: 2.837

Review 4.  In vivo cell tracking with bioluminescence imaging.

Authors:  Jung Eun Kim; Senthilkumar Kalimuthu; Byeong-Cheol Ahn
Journal:  Nucl Med Mol Imaging       Date:  2014-11-26

Review 5.  Patient-centric trials for therapeutic development in precision oncology.

Authors:  Andrew V Biankin; Steven Piantadosi; Simon J Hollingsworth
Journal:  Nature       Date:  2015-10-15       Impact factor: 49.962

Review 6.  18F-Fluoroestradiol PET: Current Status and Potential Future Clinical Applications.

Authors:  Geraldine J Liao; Amy S Clark; Erin K Schubert; David A Mankoff
Journal:  J Nucl Med       Date:  2016-06-15       Impact factor: 10.057

Review 7.  Influence of tumour micro-environment heterogeneity on therapeutic response.

Authors:  Melissa R Junttila; Frederic J de Sauvage
Journal:  Nature       Date:  2013-09-19       Impact factor: 49.962

Review 8.  Personalized Medicine Based on Theranostic Radioiodine Molecular Imaging for Differentiated Thyroid Cancer.

Authors:  Byeong-Cheol Ahn
Journal:  Biomed Res Int       Date:  2016-04-28       Impact factor: 3.411

9.  Molecular Imaging for Personalized Medicine.

Authors:  James Russell; Jie Tian; Seigo Kinuya; Baozhong Shen; Xiao-Feng Li
Journal:  Biomed Res Int       Date:  2016-08-29       Impact factor: 3.411
  9 in total
  4 in total

1.  Contribution of Radionuclide Theranostics for Managing Intractable Malignancies.

Authors:  Byeong-Cheol Ahn
Journal:  Nucl Med Mol Imaging       Date:  2018-05-24

Review 2.  Drug Discovery by Molecular Imaging and Monitoring Therapy Response in Lymphoma.

Authors:  Senthilkumar Kalimuthu; Ju Hye Jeong; Ji Min Oh; Byeong-Cheol Ahn
Journal:  Int J Mol Sci       Date:  2017-07-27       Impact factor: 5.923

Review 3.  Redifferentiation of Radioiodine Refractory Differentiated Thyroid Cancer for Reapplication of I-131 Therapy.

Authors:  Chae Moon Hong; Byeong-Cheol Ahn
Journal:  Front Endocrinol (Lausanne)       Date:  2017-10-12       Impact factor: 5.555

4.  Migration of mesenchymal stem cells to tumor xenograft models and in vitro drug delivery by doxorubicin.

Authors:  Senthilkumar Kalimuthu; Liya Zhu; Ji Min Oh; Prakash Gangadaran; Ho Won Lee; Se Hwan Baek; Ramya Lakshmi Rajendran; Arunnehru Gopal; Shin Young Jeong; Sang-Woo Lee; Jaetae Lee; Byeong-Cheol Ahn
Journal:  Int J Med Sci       Date:  2018-06-22       Impact factor: 3.738
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.